Bond Biosciences

Parkville, MO · Founded 2015 · Privately Held (backing)

Developer of small molecule-based therapeutics designed to prevent and treat ion-related human diseases. Bond Biosciences is based in Parkville, MO and was founded in 2015. Its last reported valuation was $122 million in Jan 2022. It has raised $17.1 million across 2 recorded rounds; the latest was a $5.9 million early-stage round in Apr 2026.

Last reported valuation
$121.8M
Oct 2026
Priced at
—
Total raised
$17.1M
Last round
Early Stage VC
Apr 2026
How much has Bond Biosciences raised?
$17.1Macross 2 recorded rounds · Aug 2024 – Apr 2026

Most recently, Bond Biosciences raised $5.9M in its Early Stage VC (Apr 2026).

Free account
More of Bond Biosciences with a free account
  • ·Watch Bond Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Bond Biosciences round by round

2 rounds
Apr 2026Early Stage VC$5.9MSEC filing▮
83 investors participated
Aug 2024Seed Round$4.5MSEC filing▮
91 investors participated

How much has Bond Biosciences raised?

Bond Biosciences has raised $17.1 million in total; 2 of its rounds are on record. The largest on record was a $5.9 million early-stage round in Apr 2026.

Bond Biosciences has filed 4 Form Ds with the SEC since 2024, most recently in Jan 2026 ($4.5 million sold to 91 investors).

Bond Biosciences investors

5 investors are on record for Bond Biosciences, including National Institutes of Health, BioGenerator Ventures, Collage Venture Partners and Emerald Bioventures. The early-stage round in Apr 2026 drew 83 investors.

For fundraisers
Raising for a company like Bond Biosciences?

5 investors have backed Bond Biosciences.

See all 5 investors →

Frequently asked about Bond Biosciences

How much has Bond Biosciences raised?
Bond Biosciences has raised $17.1M in total across 2 recorded funding rounds.
When was Bond Biosciences's last funding round?
Bond Biosciences's most recent recorded round was Early Stage VC in Apr 2026, raising $5.9M.